Meyer Handelman Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28M Sell
114,606
-173
-0.2% -$40.3K 0.87% 39
2025
Q4
$23.8M Sell
114,779
-5,430
-5% -$1.07M 0.74% 43
2025
Q3
$22.3M Sell
120,209
-1,950
-2% -$334K 0.7% 44
2025
Q2
$18.7M Sell
122,159
-13,950
-10% -$2.14M 0.62% 49
2025
Q1
$22.6M Sell
136,109
-1,244
-0.9% -$195K 0.79% 41
2024
Q4
$19.9M Sell
137,353
-4,376
-3% -$678K 0.69% 46
2024
Q3
$23M Sell
141,729
-6,173
-4% -$984K 0.78% 42
2024
Q2
$21.6M Sell
147,902
-2,113
-1% -$314K 0.76% 39
2024
Q1
$23.7M Buy
150,015
+15,675
+12% +$2.5M 0.83% 39
2023
Q4
$21.1M Sell
134,340
-15,750
-10% -$2.42M 0.82% 38
2023
Q3
$23.4M Buy
150,090
+15,520
+12% +$2.56M 0.94% 35
2023
Q2
$22.3M Buy
134,570
+1,123
+0.8% +$181K 0.9% 36
2023
Q1
$20.7M Sell
133,447
-3,300
-2% -$533K 0.86% 38
2022
Q4
$24.2M Sell
136,747
-13,200
-9% -$2.28M 1.01% 32
2022
Q3
$24.5M Sell
149,947
-750
-0.5% -$127K 1.13% 30
2022
Q2
$26.8M Sell
150,697
-50
-0% -$8.91K 1.15% 28
2022
Q1
$26.7M Sell
150,747
-1,580
-1% -$269K 1.02% 32
2021
Q4
$26.1M Buy
152,327
+1,060
+0.7% +$174K 0.97% 35
2021
Q3
$24.4M Sell
151,267
-5,400
-3% -$921K 1% 34
2021
Q2
$25.8M Buy
156,667
+1,300
+0.8% +$215K 1.02% 36
2021
Q1
$25.5M Buy
155,367
+500
+0.3% +$80.9K 1.06% 35
2020
Q4
$24.4M Sell
154,867
-200
-0.1% -$29.5K 1.1% 32
2020
Q3
$23.1M Sell
155,067
-1,253
-0.8% -$185K 1.17% 29
2020
Q2
$22M Sell
156,320
-2,950
-2% -$430K 1.17% 30
2020
Q1
$20.9M Hold
159,270
1.28% 27
2019
Q4
$23.2M Sell
159,270
-3,000
-2% -$407K 1.12% 27
2019
Q3
$21M Sell
162,270
-1,300
-0.8% -$171K 1.06% 34
2019
Q2
$22.8M Sell
163,570
-1,900
-1% -$263K 1.17% 29
2019
Q1
$22.9M Sell
165,470
-393
-0.2% -$52.6K 1.19% 28
2018
Q4
$21.4M Sell
165,863
-880
-0.5% -$123K 1.21% 26
2018
Q3
$23M Buy
166,743
+355
+0.2% +$47.2K 1.13% 31
2018
Q2
$20.2M Buy
166,388
+1,216
+0.7% +$152K 1.03% 36
2018
Q1
$21.2M Buy
165,172
+300
+0.2% +$40.5K 1.08% 33
2017
Q4
$23M Sell
164,872
-300
-0.2% -$41.8K 1.1% 31
2017
Q3
$21.5M Sell
165,172
-42,550
-20% -$5.64M 0.98% 36
2017
Q2
$27.5M Sell
207,722
-2,355
-1% -$300K 1.16% 32
2017
Q1
$26.2M Sell
210,077
-134
-0.1% -$16K 1.11% 29
2016
Q4
$24.2M Sell
210,211
-650
-0.3% -$75.1K 1.07% 32
2016
Q3
$24.9M Sell
210,861
-300
-0.1% -$36.4K 1.12% 30
2016
Q2
$25.6M Sell
211,161
-4,050
-2% -$460K 1.15% 30
2016
Q1
$23.3M Sell
215,211
-100
-0% -$10.4K 1.08% 32
2015
Q4
$22.1M Hold
215,311
1.05% 35
2015
Q3
$20.1M Buy
215,311
+325
+0.2% +$31.4K 1.02% 35
2015
Q2
$21M Sell
214,986
-400
-0.2% -$40.1K 0.96% 39
2015
Q1
$21.7M Buy
215,386
+11,803
+6% +$1.2M 0.98% 36
2014
Q4
$21.3M Sell
203,583
-200
-0.1% -$21.1K 0.96% 37
2014
Q3
$21.7M Sell
203,783
-700
-0.3% -$72.6K 1.01% 36
2014
Q2
$21.4M Sell
204,483
-400
-0.2% -$40.4K 0.99% 34
2014
Q1
$20.1M Sell
204,883
-100
-0% -$9.27K 0.97% 35
2013
Q4
$18.8M Sell
204,983
-1,900
-0.9% -$175K 0.91% 37
2013
Q3
$17.9M Buy
206,883
+600
+0.3% +$53.8K 0.95% 36
2013
Q2
$17.7M Buy
+206,283
New +$17.5M 0.97% 35

Other funds holding JNJ

Meyer Handelman Company's JNJ Position: Q1 2026 in Review

Meyer Handelman Company reduced its Johnson & Johnson (JNJ) stake by 0.15% in Q1 2026, selling an estimated $40.3K and leaving 114,606 shares worth $28M. The position accounts for 0.87% of the portfolio, ranked #39.

Meyer Handelman Company first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Meyer Handelman Company held 114,606 shares of Johnson & Johnson worth $28M as of Q1 2026.
  • Meyer Handelman Company sold 173 Johnson & Johnson shares in Q1 2026, an estimated $40.3K.
  • Johnson & Johnson made up 0.87% of Meyer Handelman Company's portfolio in Q1 2026, its #39 holding.
  • Meyer Handelman Company first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Meyer Handelman Company's 13F filing for Q1 2026, filed 20 Apr 2026.